176 related articles for article (PubMed ID: 7717555)
1. The maximum depth of an atracurium neuromuscular block antagonized by edrophonium to effect adequate recovery.
Beemer GH; Goonetilleke PH; Bjorksten AR
Anesthesiology; 1995 Apr; 82(4):852-8. PubMed ID: 7717555
[TBL] [Abstract][Full Text] [Related]
2. Tactile evaluation of train-of-four count as an indicator of reliability of antagonism of vecuronium- or atracurium-induced neuromuscular blockade.
Kopman AF
Anesthesiology; 1991 Oct; 75(4):588-93. PubMed ID: 1681762
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
Naguib M; Riad W
Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
[TBL] [Abstract][Full Text] [Related]
4. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
Smith CE; Donati F; Bevan DR
Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
[TBL] [Abstract][Full Text] [Related]
5. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
Sanfilippo M; Vilardi V; Fierro G; Rosa G; Pelaia P; Gasparetto A
Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
[TBL] [Abstract][Full Text] [Related]
6. Train-of-four ratio after antagonism of atracurium with edrophonium: influence of different priming doses of edrophonium.
Naguib M
Can J Anaesth; 1989 Jan; 36(1):25-9. PubMed ID: 2644050
[TBL] [Abstract][Full Text] [Related]
7. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
Lavery GG; Mirakhur RK; Gibson FM
Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
[TBL] [Abstract][Full Text] [Related]
9. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases.
Beemer GH; Bjorksten AR; Dawson PJ; Dawson RJ; Heenan PJ; Robertson BA
Br J Anaesth; 1991 Apr; 66(4):469-75. PubMed ID: 2025474
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium.
Astley BA; Hughes R; Payne JP
Br J Anaesth; 1986 Nov; 58(11):1290-5. PubMed ID: 3778793
[TBL] [Abstract][Full Text] [Related]
11. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
[TBL] [Abstract][Full Text] [Related]
12. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
Naguib M; Abdulatif M; al-Ghamdi A
Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of intense atracurium-induced neuromuscular block in children.
Gwinnutt CL; Walker RW; Meakin G
Br J Anaesth; 1991 Jul; 67(1):13-6. PubMed ID: 1859751
[TBL] [Abstract][Full Text] [Related]
14. Edrophonium antagonism of cisatracurium-induced neuromuscular block: dose requirements in children and adults.
Abdulatif M; El-Sanabary M
Anaesth Intensive Care; 2001 Aug; 29(4):364-70. PubMed ID: 11512646
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
[TBL] [Abstract][Full Text] [Related]
16. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
Donati F; Smith CE; Bevan DR
Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
[TBL] [Abstract][Full Text] [Related]
17. Edrophonium antagonism of atracurium during enflurane anaesthesia.
Gill SS; Bevan DR; Donati F
Br J Anaesth; 1990 Mar; 64(3):300-5. PubMed ID: 2328178
[TBL] [Abstract][Full Text] [Related]
18. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
Kopman AF
Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
[TBL] [Abstract][Full Text] [Related]
19. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
Caldwell JE; Robertson EN; Baird WL
Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
